 Sample Size The sample size is designed to assess multiple dose PK of piperacillin-tazobactam in young infants. At least 4 infants will be enrolled in each of the GAPNA cohorts. Infants will be enrolled to ensure that at least 4 infants with 3 evaluable PK samples are enrolled in each cohort. 